BPH - Benign Prostatic Enlargement - Results from #30

REVIEW UroToday

Incidental Prostate Cancer in Patients Undergoing Surgery for Benign Prostatic Hyperplasia: A Predictive Model. September 15, 2024

5α-reductase inhibitors with or without alpha-blockers and risk of incident upper tract urothelial carcinoma in men with benign prostatic hyperplasia: Analysis of US insurance claims data. September 9, 2024

LUTS/BPH increases the risk of depressive symptoms among elderly adults: A 5-year longitudinal evidence from CHARLS. September 6, 2024

Functional outcomes following external beam radiation therapy for patients with prior holmium laser enucleation of the prostate. September 6, 2024

A comparison of the efficacy of dutasteride on reducing lower urinary tract symptoms among patients with small versus large benign prostatic hyperplasia. September 6, 2024

Establishing and characterizing the molecular profiles, cellular features, and clinical utility of a patient-derived xenograft model using benign prostatic tissues. September 6, 2024

Hypoxia activates the hypoxia-inducible factor-1α/vascular endothelial growth factor pathway in a prostatic stromal cell line: A mechanism for the pathogenesis of benign prostatic hyperplasia. September 2, 2024

Transurethral Resection of the Prostate (TURP) and concomitant inguinal hernioplasty: a single-center experience. September 2, 2024

A Systematic Review and Single-Arm Meta-Analysis on the Efficacy of High-Intensity, Focused Ultrasound for Benign Prostatic Hyperplasia Treatment: A Forgotten Option? August 30, 2024

Clinical Outcomes in Patients with Hypocontractile Bladders Undergoing Holmium Laser Enucleation of the Prostate. August 30, 2024

A Multifaceted Assessment of Benign Prostatic Hyperplasia Practice and AUA Guideline Adherence. August 30, 2024

Comparison of Clinical Therapeutic Efficacy between TUPKP and HoLEP for Patients Aged 70 Years and Older with Benign Prostatic Hyperplasia: Retrospective Study. August 26, 2024

Factors associated with concomitant prostate cancer in benign prostatic hyperplasia patients aged 60 years and above. August 26, 2024

Prostate-specific antigen, androgen, progesterone and oestrogen receptors in Benign prostatic hyperplasia: human tissues and animal model study. August 26, 2024

Predictive Factors for Tissue Inflammation in Patients with Benign Prostatic Hyperplasia (BPH): A Clinical Prediction Study. August 19, 2024

Multiparametric-magnetic resonance imaging (mp-MRI) of the prostate and Urolift: Identifying artefact size, location and clinical implications. August 19, 2024

The 'Prostate Embolisation AS first-line therapY compAred to meDication in treatment naïVe men with prostAte eNlargement, a randomised ControllEd trial' (P-EASY ADVANCE): a randomised controlled trial of prostate embolisation vs medication for BPH. August 18, 2024

UroLift to preserve seminal parameters in young male with LUTS from BPH. August 18, 2024

Prevalence and potential predictors of incidental prostate Cancer in patients undergoing surgery for Benign Prostatic obstruction: a retrospective study in the MRI era. August 18, 2024

Comparison of Holmium and Thulium Laser Energy Effects on Prostate Enucleation: A Video Case Study August 16, 2024

Page 2 of 140